Skip to content
PubMed This is a summary of 14 peer-reviewed journal articles Updated
Dermatology

Understanding Pyoderma Gangrenosum

At a Glance

Pyoderma gangrenosum is a rare immune-driven skin condition that causes painful, rapidly worsening ulcers. It is not a bacterial infection or traditional gangrene, and minor trauma can trigger new ulcers or enlarge existing wounds through pathergy.

Pyoderma gangrenosum (PG) is a rare and often misunderstood inflammatory skin condition that causes painful, non-healing ulcers. If you are reading this, you may be dealing with an ulcer that appeared suddenly or grew rapidly, causing intense pain that feels out of proportion to what you can see on the surface. It is important to know that despite its name, PG is not an infection caused by bacteria, and it is not “gangrene” in the traditional sense [1][2]. Instead, it is a sign of a complex innate and adaptive immune dysregulation.

A Rare Immune Misfire

PG is exceptionally rare, affecting an estimated 3 to 10 people out of every million each year [3]. Because it is so uncommon, many patients spend weeks or months searching for answers while their wounds are misidentified as simple infections or surgical complications [4].

At its core, PG is a neutrophil-predominant autoinflammatory disorder. In most autoimmune diseases, the body mistakenly creates antibodies to attack its own healthy tissue. In PG, the problem lies with the “first responders” of the immune system—specifically cells called neutrophils [2]. These white blood cells are supposed to rush to a site of injury to kill bacteria and then quiet down so healing can begin. In people with PG, research suggests these cells are overactive, flooding the skin with inflammatory chemicals even when no infection is present [5]. This creates a sterile, aggressive inflammatory environment that destroys healthy skin instead of repairing it [1].

The Role of T-Cells and Cytokines

While neutrophils do the visible damage, other parts of your immune system act as the “engine” behind the inflammation. Research suggests that T-cells (another type of white blood cell) may be among the first to arrive at a new site, signaling the body to start an inflammatory response [6]. These cells release chemical messengers called cytokines—such as TNF-alpha, IL-1 beta, and IL-17—which act like an alarm system that won’t turn off [7][8]. This continuous “alarm” keeps the neutrophils in a state of high alert, leading to the characteristic rapidly spreading, “undermined” edges of a PG ulcer [9].

Understanding Pathergy: When Trauma Triggers Trouble

One of the most defining and frustrating features of PG is a phenomenon called pathergy [10]. This occurs when a minor injury to the skin—something as small as a needle stick, a scratch, or even a surgical incision—triggers the development of a new ulcer or causes an existing one to grow significantly larger [11].

Pathergy affects roughly 16% to 28% of people with PG [12][13]. It happens because the immune system in patients with PG is “primed” to overreact. When the skin is broken, the normal signal to start healing is misinterpreted as a signal to launch a massive inflammatory attack [1]. This is why doctors may be very cautious about performing biopsies or surgery on you while the disease is active; they weigh the possibility of pathergy against the need for a clinically important tissue sample [14].

The Emotional Impact of the “Invisible” Cause

Living with PG can be an isolating experience. The ulcers are often deeply painful, and because the cause is internal (immune-driven) rather than external (an infection), it can be difficult for others to understand why the wound won’t heal with standard care. The intense pain and the speed at which the skin can change are valid reasons to feel overwhelmed.

Recognizing that this is a systemic immune issue—not a failure of hygiene or a simple wound—is the first step toward finding the right management plan. While the biological “misfire” is complex, identifying the roles of neutrophils and pathergy helps your medical team move away from ineffective antibiotics and toward treatments that can calm the immune system’s overreaction.

Common questions in this guide

What is pyoderma gangrenosum?
Pyoderma gangrenosum is a rare inflammatory skin condition in which an overactive immune response damages the skin and causes painful, non-healing ulcers. It can progress quickly and may have undermined edges. Despite its name, it is not a bacterial infection and is not traditional gangrene.
Is pyoderma gangrenosum caused by an infection?
Pyoderma gangrenosum itself is not a bacterial infection. It is driven by immune-system dysregulation, with overactive neutrophils and inflammatory signals damaging otherwise healthy skin. Because its ulcers can resemble infected wounds, clinicians may still need to rule out infection with examination, cultures, or other tests.
What does pathergy mean in pyoderma gangrenosum?
Pathergy means that a minor skin injury, such as a needle stick, scratch, or surgical incision, can trigger a new PG ulcer or make an existing one grow larger. It happens because the immune system overreacts to the normal injury signal. Tell your care team about suspected pathergy before procedures so they can weigh the need for trauma against possible worsening.
How is pyoderma gangrenosum distinguished from an infection?
Clinicians assess the ulcer’s appearance, pain, speed of progression, and overall history while considering other conditions that can cause similar wounds. Biopsy and culture results may help rule out other causes, but a biopsy during active disease is weighed carefully because skin trauma can worsen PG through pathergy. Your treating clinician should interpret these findings together rather than relying on one result.
How should a pyoderma gangrenosum ulcer be cared for?
Ask your medical team for a wound-care plan that protects the ulcer while avoiding unnecessary trauma. Aggressive cleaning, scraping, or other procedures may worsen an active ulcer in people who experience pathergy. Do not change wound care or avoid a needed procedure without discussing it with the clinician treating you.
Why can pyoderma gangrenosum be so painful?
The pain can be intense because immune cells and inflammatory chemicals create ongoing inflammation that damages healthy skin. Neutrophils are key first responders, while T-cells and cytokines such as TNF-alpha, IL-1 beta, and IL-17 help keep the inflammatory response active. Share severe or rapidly changing pain with your clinician.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Which other conditions or infections have been ruled out, and what do my biopsy or culture results mean?
  2. 2.Based on the appearance of my ulcer, how confident are you that this is pyoderma gangrenosum rather than an infection?
  3. 3.I have noticed [specific trauma, like a needle stick or scratch] triggered this. Does this support pathergy in my case?
  4. 4.Are there specific activities or types of medical procedures I should avoid to prevent new ulcers?
  5. 5.How can we safely manage this wound without using aggressive cleaning or scraping that might make it worse?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (14)
  1. 1

    Pyoderma Gangrenosum: An Updated Literature Review on Established and Emerging Pharmacological Treatments.

    Maronese CA, Pimentel MA, Li MM, et al.

    American journal of clinical dermatology 2022; (23(5)):615-634 doi:10.1007/s40257-022-00699-8.

    PMID: 35606650
  2. 2

    Pyoderma gangrenosum: a review of pathogenesis and treatment.

    Ahn C, Negus D, Huang W

    Expert review of clinical immunology 2018; (14(3)):225-233 doi:10.1080/1744666X.2018.1438269.

    PMID: 29406827
  3. 3

    Epidemiology of pyoderma gangrenosum: Results from an Italian prospective multicentre study.

    Monari P, Moro R, Motolese A, et al.

    International wound journal 2018; (15(6)):875-879 doi:10.1111/iwj.12939.

    PMID: 29877043
  4. 4

    Pyoderma Gangrenosum: Diagnostic Criteria, Subtypes, Systemic Associations, and Workup.

    Zaino ML, Schadt CR, Callen JP, Owen LG

    Dermatologic clinics 2024; (42(2)):157-170 doi:10.1016/j.det.2023.08.003.

    PMID: 38423678
  5. 5

    Drug-induced pyoderma gangrenosum: a model to understand the pathogenesis of pyoderma gangrenosum.

    Wu BC, Patel ED, Ortega-Loayza AG

    The British journal of dermatology 2017; (177(1)):72-83 doi:10.1111/bjd.15193.

    PMID: 27864925
  6. 6

    Classic Ulcerative Pyoderma Gangrenosum Is a T Cell-Mediated Disease Targeting Follicular Adnexal Structures: A Hypothesis Based on Molecular and Clinicopathologic Studies.

    Wang EA, Steel A, Luxardi G, et al.

    Frontiers in immunology 2017; (8()):1980 doi:10.3389/fimmu.2017.01980.

    PMID: 29379508
  7. 7

    Autoinflammation in pyoderma gangrenosum and its syndromic form (pyoderma gangrenosum, acne and suppurative hidradenitis).

    Marzano AV, Damiani G, Ceccherini I, et al.

    The British journal of dermatology 2017; (176(6)):1588-1598 doi:10.1111/bjd.15226.

    PMID: 27943240
  8. 8

    Pyoderma gangrenosum: A systematic review of the molecular characteristics of disease.

    Flora A, Kozera E, Frew JW

    Experimental dermatology 2022; (31(4)):498-515 doi:10.1111/exd.14534.

    PMID: 35114021
  9. 9

    Epidermotropism of inflammatory cells differentiates pyoderma gangrenosum from venous leg ulcers.

    Ronicke M, Baur A, Kirr M, et al.

    Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 2022; (20(5)):619-627 doi:10.1111/ddg.14708.

    PMID: 35487858
  10. 10

    Diagnostic Criteria of Ulcerative Pyoderma Gangrenosum: A Delphi Consensus of International Experts.

    Maverakis E, Ma C, Shinkai K, et al.

    JAMA dermatology 2018; (154(4)):461-466 doi:10.1001/jamadermatol.2017.5980.

    PMID: 29450466
  11. 11

    Case Study on Management of Postsurgical Pyoderma Gangrenosum After Spinal Surgery.

    Ratliff CR

    Journal of wound, ostomy, and continence nursing : official publication of The Wound, Ostomy and Continence Nurses Society 2019; (46(6)):543-546 doi:10.1097/WON.0000000000000587.

    PMID: 31651797
  12. 12

    The Association of Age With Clinical Presentation and Comorbidities of Pyoderma Gangrenosum.

    Ashchyan HJ, Butler DC, Nelson CA, et al.

    JAMA dermatology 2018; (154(4)):409-413 doi:10.1001/jamadermatol.2017.5978.

    PMID: 29450453
  13. 13

    Underlying Systemic Diseases in Pyoderma Gangrenosum: A Systematic Review and Meta-Analysis.

    Kridin K, Cohen AD, Amber KT

    American journal of clinical dermatology 2018; (19(4)):479-487 doi:10.1007/s40257-018-0356-7.

    PMID: 29721816
  14. 14

    Wound Debridement in Pyoderma Gangrenosum.

    Taheri A, Mansoori P, Sharif M

    Advances in skin & wound care 2024; (37(2)):107-111 doi:10.1097/ASW.0000000000000092.

    PMID: 38241454

This page explains pyoderma gangrenosum and pathergy for educational purposes only; it does not diagnose ulcers or replace medical advice. Ask your dermatologist or treating clinician how to evaluate and manage your wound.

Get notified when new evidence is published on Pyoderma gangrenosum.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.